JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Honeywell
HON
$67.8B
| $1.9B | 0.23% |
10,540,373
+723,092
| +7% | +$136M |
2013 Q2
39 quarters
|
|
102
Freeport-McMoran
FCX
$103B
| $1.89B | 0.23% |
46,164,978
+3,565,680
| +8% | +$148M |
2013 Q2
39 quarters
|
|
103
Lam Research
LRCX
$435B
| $1.87B | 0.23% |
35,191,880
-2,408,910
| -6% | -$118M |
2013 Q2
39 quarters
|
|
104
iShares MSCI EAFE ETF
EFA
$76.8B
| $1.86B | 0.23% |
26,012,768
+1,210,666
| +5% | +$84.7M |
2013 Q2
39 quarters
|
|
105
Intuitive Surgical
ISRG
$138B
| $1.84B | 0.22% |
7,191,791
-1,437,571
| -17% | -$354M |
2013 Q2
39 quarters
|
|
106
iShares MSCI Japan ETF
EWJ
$23.6B
| $1.82B | 0.22% |
30,943,541
-298,019
| -1% | -$17M |
2013 Q2
39 quarters
|
|
107
Synopsys
SNPS
$93.9B
| $1.81B | 0.22% |
4,676,491
-106,494
| -2% | -$38M |
2013 Q2
39 quarters
|
|
108
Verizon
VZ
$191B
| $1.79B | 0.22% |
46,007,383
-2,161,566
| -4% | -$85.2M |
2013 Q2
39 quarters
|
|
109
CALL
Invesco QQQ Trust
QQQ
$503B
| $1.78B | 0.22% |
5,547,700
-2,783,400
| -33% | -$821M |
2013 Q2
39 quarters
|
|
110
Union Pacific
UNP
$165B
| $1.77B | 0.22% |
8,775,886
-298,496
| -3% | -$60.5M |
2013 Q2
39 quarters
|
|
111
General Dynamics
GD
$89.3B
| $1.76B | 0.21% |
7,721,235
-22,077
| -0.3% | -$5.1M |
2013 Q2
39 quarters
|
|
112
Chipotle Mexican Grill
CMG
$40.9B
| $1.76B | 0.21% |
51,394,500
+11,317,950
| +28% | +$356M |
2013 Q2
39 quarters
|
|
113
CALL
iShares S&P 100 ETF
OEF
$20.6B
| $1.73B | 0.21% |
29,945,900
-5,413,000
| -15% | -$971M |
2014 Q3
34 quarters
|
|
114
iShares Russell 2000 ETF
IWM
$76.8B
| $1.72B | 0.21% |
9,618,012
+6,905,332
| +255% | +$1.27B |
2013 Q2
39 quarters
|
|
115
Boston Scientific
BSX
$61.7B
| $1.68B | 0.21% |
33,677,881
-13,747,665
| -29% | -$648M |
2013 Q2
39 quarters
|
|
116
Northrop Grumman
NOC
$67.9B
| $1.68B | 0.2% |
3,640,810
+833,472
| +30% | +$387M |
2013 Q2
39 quarters
|
|
117
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $1.67B | 0.2% |
33,442,355
+11,881,190
| +55% | +$605M |
2013 Q2
39 quarters
|
|
118
CALL
SPDR Gold Trust
GLD
$141B
| $1.67B | 0.2% |
9,117,800
-4,520,300
| -33% | -$795M |
2014 Q3
34 quarters
|
|
119
CVS Health
CVS
$111B
| $1.67B | 0.2% |
22,461,652
-4,232,239
| -16% | -$355M |
2013 Q2
39 quarters
|
|
120
Medtronic
MDT
$110B
| $1.64B | 0.2% |
20,349,983
+327,737
| +2% | +$26.7M |
2013 Q2
39 quarters
|
|
121
iShares Russell 1000 Growth ETF
IWF
$130B
| $1.64B | 0.2% |
26,778,244
-2,206,748
| -8% | -$127M |
2013 Q2
39 quarters
|
|
122
Marriott International
MAR
$93.6B
| $1.62B | 0.2% |
9,748,596
-250,280
| -3% | -$41.7M |
2013 Q2
39 quarters
|
|
123
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
$2.03B
| $1.59B | 0.19% |
21,075,645
+3,001,725
| +17% | +$230M |
2020 Q3
10 quarters
|
|
|
AMJ
124
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $1.58B | 0.19% |
71,317,554
+4,181,619
| +6% | +$94.4M |
2013 Q2
39 quarters
|
|
|
SCHW
125
Charles Schwab
SCHW
$167B
| $1.57B | 0.19% |
29,941,276
-3,788,487
| -11% | -$277M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.